COVID VACCINE INVESTING. Up to date information about the smaller bio-pharmaceutical companies developing a COVID vaccine. This blog features a COVID INVESTOR INDEX which keeps track of the relative performance of 28 key COVID VACCINE companies.
Thursday 20 January 2022
Pain continues - 2.7% losses on average overall
No double digit losses, but another painful 2.7% loss overall. Fully seven stocks lost 5% or more.
Only EBS and Dynavax gained.
Tonix and IBio lead on the way down with losses in the 6.5% range.
No comments:
Post a Comment